Kiniksa Pharmaceuticals, Ltd.【KNSA】 業績推移・財務諸表

(単位:千ドル) 2Q18 3Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 - - - - - - - - - 7,704 12,095 32,189 26,972 99,135 48,345 71,473 67,046 79,858 108,631 112,214 137,785 156,797
売上成長率(%) - - - - - - - - - - - -
売上原価 - - - - - - - - - 2,466 2,767 - - - - 7,699 9,088 10,583 12,322 20,109 17,868 18,603
研究開発費 17,200 20,644 59,253 30,848 22,014 20,901 22,324 31,419 28,683 23,945 19,236 20,817 13,798 16,485 15,172 23,767 17,106 26,334 24,017 26,057 19,325 18,753
販売管理費 - - - - - - - - - 21,848 20,759 22,218 23,841 24,677 29,045 29,175 34,468 38,682 42,395 46,399 43,530 46,863
営業費用 21,527 26,159 67,647 39,289 30,446 29,387 31,860 43,218 49,283 - - - - - - - - - - - - -
営業利益 -21,527 -26,159 -67,647 -39,289 -30,446 -29,387 -31,860 -43,218 -49,283 -40,555 -30,667 -23,319 -19,368 46,413 -11,196 -3,154 -10,927 -16,542 -117 -9,658 13,272 20,160
営業利益率 (%) - - - - - - - - -
経常(税引前)利益 -20,461 -24,537 -65,838 -37,565 -29,060 -28,598 -31,594 -43,169 -49,274 -40,549 -30,662 -23,285 -19,265 46,735 -9,364 -1,239 -8,499 -14,276 2,304 -7,201 15,565 22,877
経常(税引前)利益率(%) - - - - - - - - - -526.34 -253.51 -72.34 -71.43 47.14 -19.37 -1.73 -12.68 -17.88 2.12 -6.42 11.3 14.59
法人税等合計 -202 -131 -17 -374 -2,002 -2,179 5,875 667 210 1,014 -118 1,925 716 -177,358 2,906 -16,211 5,356 3,428 6,212 5,492 7,026 5,045
実効税率(%)
純利益 -20,259 -24,406 -65,821 -37,191 -27,058 -26,419 -37,469 -43,836 -49,484 -41,563 -30,544 -25,210 -19,981 224,093 -12,270 14,972 -13,855 -17,704 -3,908 -12,693 8,539 17,832
純利益率(%) - - - - - - - - -
一株あたり利益 - - - - - - - - - - - -0.36 -0.29 3.23 -0.18 0.21 -0.2 -0.25 -0.06 -0.18 0.12 0.24
希薄化後一株あたり利益 - - - - - - - - - - - -0.36 -0.29 3.18 -0.18 0.21 -0.2 -0.25 -0.06 -0.18 0.11 0.23